Can you take Wegovy with hypothyroidism?

Hypothyroidism (aka underactive thyroid) can make weight loss more difficult, which is why some people consider weight loss medications like Wegovy (semaglutide). At the same time, it’s natural to wonder whether you can take Wegovy with hypothyroidism — especially because it carries a warning about not taking it if you have a history of a specific kind of thyroid cancer. 

Luckily, that specific kind of thyroid cancer is rare, not connected to hypothyroidism, and it’s safe for most people to take hypothyroidism medication with Wegovy (under a healthcare provider’s care, of course). There are, however, a few important things to know about the drug and thyroid health before starting treatment. 

Yes, many people with hypothyroidism can take Wegovy safely under the guidance of a healthcare provider. Hypothyroidism itself is not considered a reason someone should avoid taking the Wegovy pill or weekly injection.

Still, there are a few important exceptions. 

First, Wegovy carries a boxed warning from the United States Food and Drug Administration (FDA) about thyroid C-cell tumors seen in rodents. That’s why it’s generally not recommended for people with a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). 

However, these conditions are rare and distinct from the common causes of hypothyroidism (like Hashimoto’s disease). For most people with hypothyroidism, there’s no strong evidence that Wegovy directly harms the thyroid or makes hypothyroidism worse. 

Because Wegovy slows digestion, it can sometimes affect how the body absorbs oral medications, including thyroid medication. That’s one reason your healthcare provider may want to monitor your thyroid levels more closely after you start treatment or lose a significant amount of weight. In some cases, they may need to adjust your dosage.

See if you qualify

No, Wegovy does not treat hypothyroidism. It’s not a thyroid medication, so it won’t correct low thyroid hormone levels or replace research-backed treatments like levothyroxine.

That said, Wegovy may still help some people with hypothyroidism manage their symptoms indirectly, particularly if weight gain has been part of the picture. 

Research shows semaglutide can lead to significant weight loss in people with obesity or overweight. This can improve overall metabolic health and reduce some of the physical strain associated with excess weight, and that’s true whether your excess weight is coming from a thyroid-related disorder or not.

For some people, losing weight may also improve energy levels, mobility, sleep, blood sugar control, or conditions that commonly overlap with hypothyroidism (like high cholesterol or sleep apnea). 

But it’s important to keep expectations realistic: Wegovy doesn’t “fix” an underactive thyroid, and most people with hypothyroidism will still need ongoing thyroid hormone treatment.

Healthcare providers also typically recommend making sure hypothyroidism is properly treated before assuming thyroid-related weight gain requires additional medication. In some cases, adjusting thyroid medication alone may help stabilize weight or improve symptoms without the need for support from a GLP-1 (glucagon-like peptide-1 receptor agonist).

Possibly, but it depends on the cause of the hyperthyroidism and your overall health history. Hyperthyroidism itself is not automatically considered a reason someone can’t take Wegovy, but healthcare providers may want to monitor symptoms and medications more closely.

Hyperthyroidism is a condition where the thyroid produces too much thyroid hormone (the opposite of hypothyroidism). This can cause symptoms like rapid heartbeat, anxiety, tremors, diarrhea, and unintended weight loss. Because Wegovy can also cause gastrointestinal side effects and affect appetite, providers may want to make sure your thyroid condition is stable before starting treatment.

Ultimately, if you’re interested in Wegovy and have hyperthyroidism, it’s best to talk with a healthcare provider first. They can review your health and treatment plan to determine if a GLP-1 is appropriate for you.

Yes, many people can take Wegovy while on thyroid medication. But because Wegovy slows stomach emptying, it may affect how your body absorbs some oral medications, including thyroid drugs. That’s one reason healthcare providers may want to monitor your thyroid levels more closely after you start treatment.

Here’s what there is to know about some common thyroid medications and Wegovy:

• Levothyroxine (Synthroid, Levoxyl, Unithroid): Many people take levothyroxine and Wegovy together safely. Some research suggests semaglutide may increase levothyroxine levels in the body (by as much as 33%), so your provider may occasionally monitor your thyroid labs and decrease your dose if needed.

• Liothyronine (Cytomel): There’s limited research on this specific combination, but slowed digestion could potentially affect how well you absorb the drug. Closer monitoring may be needed.

• Combination T3/T4 therapy or compounded thyroid medication: Many people can still take these medications with Wegovy, but your provider may want to monitor thyroid levels more closely since these treatments are often highly individualized.

• Methimazole or propylthiouracil (PTU): There’s currently no strong evidence that Wegovy directly interferes with these hyperthyroidism medications. However, as with any oral medication, your healthcare provider should continue monitoring you. 

• Natural desiccated thyroid medications (Armour Thyroid, NP Thyroid): Like other oral thyroid drugs, slowed stomach emptying could potentially affect how your body absorbs these medications.

Because Wegovy carries a warning about specific types of thyroid tumors seen in animal studies, a lot of people understandably have questions about cancer risk. Researchers still aren’t sure whether Wegovy causes the same type of tumors in humans, but the warning is serious enough that some people are advised not to take the medication. 

Can you take Wegovy with thyroid cancer?

For the most common types of thyroid cancer, it may be possible (as long as your healthcare provider is okay with it), with the exception of a specific type of thyroid cancer called medullary thyroid cancer (MTC). Wegovy is generally not recommended for people with a personal or family history of:

• MTC: This is a rare type of thyroid cancer that starts in the thyroid’s C cells, which are the same cells involved in the animal studies behind Wegovy’s warning. 

• MEN2: This is a rare inherited condition that raises the risk of several endocrine tumors, including MTC.

That said, not all thyroid cancers are the same. The FDA warning specifically focuses on MTC and MEN2, so it may be possible to safely use the GLP-1 if you have a history of a more common thyroid cancer (like papillary thyroid cancer or follicular thyroid cancer).

Ultimately, if you currently have or used to have thyroid cancer, it’s important to talk with your healthcare provider before starting Wegovy. They can help weigh the potential risks and benefits based on your specific situation.

Can Wegovy increase your risk for thyroid cancer?

For most types of thyroid cancers, it seems unlikely, but for medullary thyroid cancer specifically, the truth is, researchers don’t know for sure. There’s an FDA box warning about MTC because Wegovy was shown to cause thyroid C-cell tumors in rodents during animal studies. Human studies have not clearly shown the same risk.

So far, evidence linking GLP-1 medications like semaglutide to thyroid cancer in humans is mixed. Some studies have found no substantial increase in thyroid cancer risk. Others have suggested there may be a small link that warrants further investigation. Overall, researchers agree that more long-term human data is needed.

It’s also important to understand that the warning about MTC does not mean Wegovy has been proven to cause other, more common thyroid conditions like hypothyroidism or hyperthyroidism.

Check in with your healthcare provider if you notice new or worsening thyroid-related symptoms after starting Wegovy, especially if you already have a thyroid condition or take thyroid medication.

That includes symptoms like:

• New or worsening fatigue

• Unusual weight changes

• Heart palpitations

• Shakiness or anxiety

• Increased constipation

In particular, contact your healthcare provider right away if you notice:

• Trouble swallowing

• A lump, swelling, or pain in the neck

• Hoarseness that doesn’t go away

• Shortness of breath

You should also talk to your provider if your thyroid medication suddenly seems to be working differently after starting Wegovy, since semaglutide can affect how your body absorbs some medications.

Check for free

For many people with hypothyroidism, Wegovy is safe to take along with their thyroid medication. But like any medication, it’s important to understand the potential risks.

• Having hypothyroidism alone usually doesn’t prevent someone from taking Wegovy.

• Many people take Wegovy and thyroid medication together safely, though healthcare providers may want to monitor thyroid levels more closely.

• Wegovy can help with weight loss, but it does not treat hypothyroidism directly or replace thyroid medication.

• The medication carries an FDA boxed warning about a specific type of thyroid cancer called MTC and is generally not recommended for people with a personal or family history of MTC or MEN2. 

• If you notice new or worsening thyroid-related symptoms after starting treatment, check in with your healthcare provider.